These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38057778)

  • 41. Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old.
    Polvikoski TM; van Straaten EC; Barkhof F; Sulkava R; Aronen HJ; Niinistö L; Oinas M; Scheltens P; Erkinjuntti T; Kalaria RN
    Neurology; 2010 Dec; 75(23):2071-8. PubMed ID: 21048201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease.
    Kandiah N; Chander R; Zhang A; Yee CC
    J Neurol Sci; 2014 Feb; 337(1-2):162-6. PubMed ID: 24378065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Classification of delusions in Alzheimer's disease and their neural correlates.
    Nomura K; Kazui H; Wada T; Sugiyama H; Yamamoto D; Yoshiyama K; Shimosegawa E; Hatazawa J; Takeda M
    Psychogeriatrics; 2012 Sep; 12(3):200-10. PubMed ID: 22994619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased regional white matter hyperintensity volume in objectively-defined subtle cognitive decline and mild cognitive impairment.
    Calcetas AT; Thomas KR; Edmonds EC; Holmqvist SL; Edwards L; Bordyug M; Delano-Wood L; Brickman AM; Bondi MW; Bangen KJ; For The Alzheimer's Disease Neuroimaging Initiative
    Neurobiol Aging; 2022 Oct; 118():1-8. PubMed ID: 35809348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Misclassified tissue volumes in Alzheimer disease patients with white matter hyperintensities: importance of lesion segmentation procedures for volumetric analysis.
    Levy-Cooperman N; Ramirez J; Lobaugh NJ; Black SE
    Stroke; 2008 Apr; 39(4):1134-41. PubMed ID: 18323507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Chen YF; Wang H; Chu Y; Huang YC; Su MY
    Dement Geriatr Cogn Disord; 2006; 22(2):177-84. PubMed ID: 16912479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Not all age-related white matter hyperintensities are the same: a magnetization transfer imaging study.
    Spilt A; Goekoop R; Westendorp RG; Blauw GJ; de Craen AJ; van Buchem MA
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1964-8. PubMed ID: 17032876
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and Biological Correlates of White Matter Hyperintensities in Patients With Behavioral-Variant Frontotemporal Dementia and Alzheimer Disease.
    Huynh K; Piguet O; Kwok J; Dobson-Stone C; Halliday GM; Hodges JR; Landin-Romero R
    Neurology; 2021 Mar; 96(13):e1743-e1754. PubMed ID: 33597290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlations between MRI white matter lesion location and executive function and episodic memory.
    Smith EE; Salat DH; Jeng J; McCreary CR; Fischl B; Schmahmann JD; Dickerson BC; Viswanathan A; Albert MS; Blacker D; Greenberg SM
    Neurology; 2011 Apr; 76(17):1492-9. PubMed ID: 21518999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. White matter hyperintensity topography in Alzheimer's disease and links to cognition.
    Garnier-Crussard A; Bougacha S; Wirth M; Dautricourt S; Sherif S; Landeau B; Gonneaud J; De Flores R; de la Sayette V; Vivien D; Krolak-Salmon P; Chételat G
    Alzheimers Dement; 2022 Mar; 18(3):422-433. PubMed ID: 34322985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Correlation Between White Matter Hyperintensity Burden and Regional Brain Volumetry in Patients With Alzheimer's Disease.
    Cao Z; Mai Y; Fang W; Lei M; Luo Y; Zhao L; Liao W; Yu Q; Xu J; Ruan Y; Xiao S; Mok VCT; Shi L; Liu J;
    Front Hum Neurosci; 2022; 16():760360. PubMed ID: 35774484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
    Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
    J Alzheimers Dis; 2021; 80(2):877-883. PubMed ID: 33579856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.
    Lee S; Viqar F; Zimmerman ME; Narkhede A; Tosto G; Benzinger TL; Marcus DS; Fagan AM; Goate A; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Ryan NS; Förster S; Laske C; Schofield PR; Sperling RA; Salloway S; Correia S; Jack C; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
    Ann Neurol; 2016 Jun; 79(6):929-39. PubMed ID: 27016429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early-Stage MRI Volumetric Differences in White Matter Hyperintensity and Temporal Lobe Volumes between Autopsy-Confirmed Alzheimer's Disease, Cerebral Small Vessel Disease, and Mixed Pathologies.
    Yang D; Masurkar A
    Dement Geriatr Cogn Dis Extra; 2022; 12(1):69-75. PubMed ID: 35702161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease.
    Lee S; Zimmerman ME; Narkhede A; Nasrabady SE; Tosto G; Meier IB; Benzinger TLS; Marcus DS; Fagan AM; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Fӧrster S; Schofield PR; Sperling RA; Johnson KA; Chhatwal JP; Salloway S; Correia S; Jack CR; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
    PLoS One; 2018; 13(5):e0195838. PubMed ID: 29742105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. White matter hyperintensities and mild behavioral impairment: Findings from the MEMENTO cohort study.
    Miao R; Chen HY; Robert P; Smith EE; Ismail Z;
    Cereb Circ Cogn Behav; 2021; 2():100028. PubMed ID: 36324720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional white matter hyperintensities in posterior cortical atrophy and logopenic progressive aphasia.
    Pham NTT; Graff-Radford J; Machulda MM; Spychalla AJ; Schwarz CG; Senjem ML; Lowe VJ; Vemuri P; Kantarci K; Knopman DS; Petersen RC; Jack CR; Josephs KA; Whitwell JL
    Neurobiol Aging; 2022 Nov; 119():46-55. PubMed ID: 35970009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease.
    Sultzer DL; Brown CV; Mandelkern MA; Mahler ME; Mendez MF; Chen ST; Cummings JL
    Am J Psychiatry; 2003 Feb; 160(2):341-9. PubMed ID: 12562582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.